Here is the part most investors miss.
In regulated medicine, demand is not the hard part.
Legal supply is.
Licenses take time. Inspections are strict. Export permits are detailed. Batch testing has to be perfect.
That creates natural bottlenecks.
One small public company has already cleared those hurdles and is supplying finished psychedelic products into live prescription channels.
Yet the stock still trades like the story is early and optional.
These windows usually close once the market connects execution to value.
Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.
This message is a paid advertisement for Optimi Health Corp. (OPTI) from Market Jar Media Inc. Wealthpire, Inc. receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $5,500. Other than the compensation received for this advertisement sent to subscribers, Wealthpire, Inc. and its principals are not affiliated with either Optimi Health Corp. (OPTI) or Market Jar Media Inc. Wealthpire, Inc. and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither Wealthpire, Inc. nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Wealthpire, Inc. to buy or sell any security. Wealthpire, Inc. has not evaluated the accuracy of any claims made in this advertisement. Wealthpire, Inc. recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Optimi Health Corp. (OPTI) on Market Jar Media Inc. website for additional information about the relationship between Market Jar Media Inc. and Optimi Health Corp. (OPTI).
